Published in Genetics and Environmental Health Week, October 26th, 2005
In addition, HIP's clinical performance for its Medicaid HMO in the areas of diabetes, heart disease and mental healthcare was rated in the top 10% of all plans in the nation and the asthma care in the top 25% of all health plans in the region (New York, New Jersey, Puerto Rico and U.S. Virgin Islands).
At the same time, NCQA rated HIP "Commendable" for the third consecutive time for its commercial and Medicare lines of business. HIP is the largest Medicare insurer in New York State....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.